2,864 results match your criteria American journal of therapeutics[Journal]


Immune Checkpoint Inhibitors-Related Cardiotoxicity.

Am J Ther 2019 Apr 16. Epub 2019 Apr 16.

Division of Cardiology, Westchester Medical Center, New York Medical College, Valhalla, NY.

Background: Immunotherapy is a significant breakthrough in cancer therapy in the last decade. Immunotherapy is better tolerated compared with chemotherapy. However, it does have side effects, and one of the rare and serious side effects of immunotherapy is cardiotoxicity. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000988DOI Listing

Therapeutic Implications of Inherited Thrombophilia in Pregnancy.

Am J Ther 2019 Apr 12. Epub 2019 Apr 12.

University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.

Background: Inherited (hereditary) thrombophilia is a genetic disorder that affects coagulation, being responsible for more than 60% of idiopathic (spontaneous or unprovoked) thromboembolic events. Association of inherited thrombophilia with pregnancy increases the risk of thromboembolic disease, and it may be related to many complications, such as preeclampsia, recurrent miscarriage intrauterine growth restriction, early detachment of placenta, and prematurity.

Areas Of Uncertainty: Interpretation of a positive test for thrombophilia in pregnant women is difficult because they have many natural changes in the coagulation system. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000985DOI Listing
April 2019
1 Read

Implantable Diuretic Pump for Heart Failure Management.

Authors:
Ahmed S Yassin

Am J Ther 2019 Apr 12. Epub 2019 Apr 12.

Department of Internal Medicine, Wayne State University School of Medicine, Detroit Medical Center, Detroit, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000984DOI Listing

Efficacy and Safety of Fluoxetine in Autism Spectrum Disorder: A Meta-analysis.

Am J Ther 2019 Apr 2. Epub 2019 Apr 2.

Department of Pediatrics, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000978DOI Listing
April 2019
6 Reads

Should We Use Tegaserod for Irritable Bowel Syndrome?

Am J Ther 2019 Mar 29. Epub 2019 Mar 29.

Department of Neurology, Stroke Unit, Johns Hopkins University, Towson, MD.

Background: Tegaserod, a serotonin (5-HT4) agonist initially approved for constipation but withdrawn from use in 2007 because of concerns about cardiovascular adverse effects, was resubmitted to the Food and Drug Administration (FDA) in 2018 for use in a restricted population.

Areas Of Uncertainty: Despite an 18-year regulatory history, there remain pharmacology and clinical trial concerns that have not been addressed but are critical for proper assessment of the drug safety and efficacy profile.

Sources: Original FDA reviews, FDA and developer advisory committee briefing documents, and published literature. Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00045391-900000000-9847
Publisher Site
http://dx.doi.org/10.1097/MJT.0000000000000947DOI Listing
March 2019
3 Reads

Sildenafil for Pulmonary Arterial Hypertension.

Am J Ther 2019 Mar 29. Epub 2019 Mar 29.

Department of Medicine, Division of Cardiology, East Tennessee State University, Johnson City, TN.

Pulmonary hypertension is a life-threatening illness with debilitating physical and emotional consequences. The progression of this devastating disease is characterized by a continuous increase in pulmonary vascular resistance, which results in elevated pulmonary artery pressure and leads to right heart failure. Treatment is focused on targeting the underlying complex etiology via the endothelin, prostacyclin, and nitric oxide (NO) pathways. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000766DOI Listing
March 2019
1.127 Impact Factor

Real-World Experience With Pembrolizumab in Patients With Advanced Lung Cancer.

Am J Ther 2019 Apr 1. Epub 2019 Apr 1.

Department of Pharmacy, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan, Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000762DOI Listing
April 2019
1 Read

Dapsone for Unresponsive Granulomatous Rosacea.

Am J Ther 2019 Apr 1. Epub 2019 Apr 1.

Di.S.Sal. Section of Dermatology, University of Genoa, San Martino Polyclinic Hospital, Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000903DOI Listing

Prevention of Recurrent Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators-A Network Meta-analysis.

Am J Ther 2019 Apr 1. Epub 2019 Apr 1.

Background: The optimal management for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators (ICDs) offers a challenge with no set guidelines regarding which therapy offers a best safety and efficacy profile.

Study Question: Which therapeutic strategy, among antiarrhythmic drugs and catheter ablation (CA), offers the most effective and safe approach in patients with ICDs?

Data Sources: Randomized controlled trials (RCTs) comparing the efficacy and safety of antiarrhythmic drugs or CA against a placebo group. RCTs were identified from a comprehensive search in PubMed, Embase, and Cochrane library. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000928DOI Listing
April 2019
4 Reads

Pazopanib-Associated Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome: A Case Report.

Am J Ther 2019 Apr 1. Epub 2019 Apr 1.

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000840DOI Listing
April 2019
1 Read

Secondary Cavitary Pulmonary Tuberculosis After Apatinib Treatment in Lung Squamous Cell Cancer.

Am J Ther 2019 Mar 21. Epub 2019 Mar 21.

Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000976DOI Listing
March 2019
4 Reads

Diltiazem and Hiatal Hernia: An Unknown Association.

Am J Ther 2019 Mar 20. Epub 2019 Mar 20.

Department of Internal Medicine, Maulana Azad Medical College, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000975DOI Listing
March 2019
11 Reads
1.127 Impact Factor

Electroconvulsive Therapy for Anticholinergic and Benzodiazepine Nonresponsive Tardive Oculogyric Crisis: A Case Report.

Am J Ther 2019 Mar 7. Epub 2019 Mar 7.

Department of Psychiatry, Beitou Branch, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000971DOI Listing
March 2019
4 Reads

Procedural Outcomes of Patients With Heart Failure Undergoing Catheter Ablation of Atrial Fibrillation.

Am J Ther 2019 Mar 8. Epub 2019 Mar 8.

Division of Cardiovascular Diseases, Section of Heart Failure and Transplant, University of Iowa Hospitals and Clinics, Iowa City, IA.

Background: Catheter ablation is being increasingly performed for rhythm control of atrial fibrillation (AF). Heart failure (HF) frequently coexists with AF because they share common risk factors.

Study Question: This study aims at identifying the characteristics and procedural outcomes of patients with HF undergoing catheter ablation of AF. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000931DOI Listing
March 2019
6 Reads

Increased Human Growth Hormone After Oral Consumption of an Amino Acid Supplement: Results of a Randomized, Placebo-Controlled, Double-Blind, Crossover Study in Healthy Subjects.

Am J Ther 2019 Mar 8. Epub 2019 Mar 8.

Pennington Biomedical Research Center, LSU System, Baton Rouge, LA.

Background: Human growth hormone (hGH) is best known for influencing bone and muscle growth, as well as body composition, but the use of recombinant hGH is controversial. Amino acids are a potentially safer alternative; however, preliminary investigations of the effects of oral amino acids on hGH release have been inconclusive. Therefore, we tested the effects of a novel blend of amino acids optimized to increase hGH release. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000893DOI Listing

Intravenous Administration of Low-Molecular-Weight Heparin.

Am J Ther 2019 Mar 8. Epub 2019 Mar 8.

Department of Transplantation, Tianjin First Central Hospital, Tianjin, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000841DOI Listing

Abiraterone and Aortic Dissection.

Am J Ther 2019 Mar 8. Epub 2019 Mar 8.

Department of Imaging, Laniado Hospital, Sanz Medical Center, Netanya, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000831DOI Listing
March 2019
1 Read

Mesalamine-Associated Sinus Bradycardia.

Am J Ther 2019 Mar 14. Epub 2019 Mar 14.

Department of Medicine, St. Vincent's Medical Center, Bridgeport, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000932DOI Listing
March 2019
1 Read

Anagrelide Therapy Complicated by Pneumonitis: Drug Toxicity or Lupus Flare?

Am J Ther 2019 Mar 11. Epub 2019 Mar 11.

Department of Pulmonary, Critical Care and Sleep Medicine, State University of New York, Buffalo, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000966DOI Listing
March 2019
1 Read

Drug-Induced Liver Injury Due to Dulaglutide Use.

Am J Ther 2019 Mar 12. Epub 2019 Mar 12.

Sandra Atlas Bass Center for Liver Diseases, Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000826DOI Listing

Topiramate Augmentation in the Treatment of a Patient With Schizophrenia and Paraphilia Behaviors.

Am J Ther 2019 Mar 6. Epub 2019 Mar 6.

Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000964DOI Listing

Life-Threatening Serotonin Syndrome Due to Methylene Blue-Citalopram Interaction.

Am J Ther 2019 Mar 6. Epub 2019 Mar 6.

Pulmonary and Critical Care, Maimonides Medical Center, Brooklyn, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000897DOI Listing

Oral Care and Ventilator-Associated Pneumonia.

Am J Ther 2019 Mar 6. Epub 2019 Mar 6.

Pulmonary and Critical Care Medicine, Maimonides Medical Center, New York City, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000878DOI Listing
March 2019
2 Reads

Therapeutic Advances in Emergency Cardiology: A Focus on Acute Myocarditis.

Am J Ther 2019 Mar/Apr;26(2):e294-e300

Cardiology Department, Victor Babeş University of Medicine and Pharmacy, Timişoara, Romania.

Background: Myocarditis, defined as an inflammation of the myocardium, is an important cause of dilated cardiomyopathy and congestive heart failure. Unfortunately, its diagnosis and etiology is often challenging in clinical practice, and thus, improving diagnosis and therapeutic approach of this cardiac pathology is a matter of great interest.

Areas Of Uncertainty: The etiology of the disease may be represented by not only infectious agents, usually with viral determination, but also autoimmune and systemic diseases or drugs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000921DOI Listing
March 2019
2 Reads

New Directions in the Management of Peripheral Artery Disease.

Am J Ther 2019 Mar/Apr;26(2):e284-e293

General Medicine Faculty, Cardio-Thoracic Department, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

Background: Peripheral artery disease represents an important chapter of cardiovascular pathology in which atherosclerosis (promoted by major risk factors-hypertension, smoking, dyslipidemia, and diabetes mellitus) is the major etiology. The severity of this pathology is not only due to local injury but also due to frequent association with atherosclerotic disease with other localizations, thus increasing cardiovascular morbidity and mortality in these patients. Diagnosis is based on clinical data, functional tests (the ankle-brachial index is very useful in these cases) and imagistic methods (Doppler ultrasonography, computed tomography angiography, magnetic resonance angiography, and digital subtraction angiography). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000916DOI Listing
March 2019
2 Reads

Cardiac Arrest in Special Circumstances-Recent Advances in Resuscitation.

Am J Ther 2019 Mar/Apr;26(2):e276-e283

Department of Emergency Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.

Background: Cardiopulmonary resuscitation (CPR) in special circumstances includes the emergency intervention for special causes, special environments, and special patients. Special causes cover the potential reversible causes of cardiac arrest that must be identified or excluded during any resuscitation act. The special environments section includes recommendations for the treatment of cardiac arrest occurring in specific locations: cardiac surgery, catheterization laboratory, dialysis unit, dental surgery, commercial airplanes or air ambulances, playing field, difficult environment (eg, drowning, high altitude, avalanche, and electrical injuries) or mass casualty incident. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000927DOI Listing
March 2019
8 Reads

Novel Therapeutic Options in the Management of Reflex Syncope.

Am J Ther 2019 Mar/Apr;26(2):e268-e275

Cardiology Department, CHU La Timone, Marseille, France.

Background: Syncope is a symptom associated with a wide range of pathological conditions, ranging from benign to life threatening. The most frequent is the reflex syncope that may be challenging to treat because of the complex and partially unknown pathophysiological mechanism that has to be addressed by the chosen therapy.

Areas Of Uncertainty: Head-up tilt testing is so far the only clinical test able to reproduce reflex syncope, but its diagnostic yield has been recently redefined. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000923DOI Listing
March 2019
1 Read

Update in Electrical Storm Therapy.

Am J Ther 2019 Mar/Apr;26(2):e257-e267

Heart and Vascular Center, Semmelweis University, Budapest, Hungary.

Background: Electrical storm (ES) is a major life-threatening event, which announces a possible negative outcome and poor prognosis and poses challenging questions concerning etiology and management.

Data Sources: A literature search was conducted through MEDLINE and EMBASE (past 30 years until the end of September 2018) using the following search terms: ES, ventricular fibrillation, ventricular tachycardia, ablation, and implantable defibrillator. Clinicaltrials. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000918DOI Listing
March 2019
6 Reads

Therapeutic Advances in Emergency Cardiology: Acute Pulmonary Embolism.

Am J Ther 2019 Mar/Apr;26(2):e248-e256

County Emergency Hospital, Baia Mare, Romania.

Background: Acute pulmonary embolism (PE) requires rapid diagnosis and early and appropriate treatment, often under conditions of hemodynamic instability. The therapeutic strategy should optimally integrate the therapeutic arsenal in a multidisciplinary but unitary approach.

Areas Of Uncertainty: The short list of the major uncertainties associated with acute PE should include limited general public awareness on venous thromboembolism, acute hemodynamic support not based on evidence from randomized clinical trials, with few updates lately, mainly linked to extracorporeal membrane oxygenation, thrombolytic therapy having firm indications only in high-risk PE, without clear strategies for particular clinical situations (ie, stroke, tumors, thrombi in transit, and cardiac arrest), using old therapeutic agents with old administration regimens, lack of evidence from large-volume trials on the optimal interventional approach, and relatively imprecise indications for surgical treatment. Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00045391-201904000-0000
Publisher Site
http://dx.doi.org/10.1097/MJT.0000000000000917DOI Listing
March 2019
11 Reads
1.127 Impact Factor

Therapeutic Advances in the Management of Cardiogenic Shock.

Am J Ther 2019 Mar/Apr;26(2):e234-e247

University of Medicine "Carol Davila," Bucharest.

Background: Cardiogenic shock (CS) is a life-threatening state of tissue hypoperfusion, associated with a very high risk of mortality, despite intensive monitoring and modern treatment modalities. The present review aimed at describing the therapeutic advances in the management of CS.

Areas Of Uncertainty: Many uncertainties about CS management remain in clinical practice, and these relate to the intensity of invasive monitoring, the type and timing of vasoactive therapies, the risk-benefit ratio of mechanical circulatory support (MCS) therapy, and optimal ventilation mode. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000920DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404765PMC
March 2020
8 Reads

Therapeutic Advances in the Management of Acute Decompensated Heart Failure.

Am J Ther 2019 Mar/Apr;26(2):e222-e233

University of Medicine "Carol Davila," Bucharest, Romania.

Background: Acute decompensated heart failure (ADHF) is the most common presenting phenotype of acute heart failure (AHF). The main goal of this article was to review the contemporary management strategies in these patients and to describe how future clinical trials may address unmet clinical needs.

Areas Of Uncertainty: The current pathophysiologic understanding of AHF is incomplete. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000919DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404761PMC
March 2020
2 Reads
1.127 Impact Factor

Therapeutic Challenges in Patients With Noncardioembolic Acute Ischemic Stroke in Need of Double Antiplatelet Therapy for Coronary Artery Disease.

Am J Ther 2019 Mar/Apr;26(2):e213-e221

Discipline of Neurology, University Emergency Hospital Bucharest, University of Medicine and Pharmacy "Carol Davila," Bucharest, Romania.

Background: The risk of ischemic stroke (IS) is significant within 6-12 months from the myocardial revascularization for an acute cardiac event. Consequently, we can expect to have patients with an acute IS occurring right in the time frame of dual antiplatelet therapy (DAPT) imposed by the coronary heart disease (CHD).

Areas Of Uncertainty: Until present, there are no evidence-based guidelines for the management of patients with acute IS in need of DAPT for ischemic heart disease. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000924DOI Listing
March 2019
2 Reads

Current Perspectives in Facilitated Angioplasty.

Am J Ther 2019 Mar/Apr;26(2):e208-e212

Cardiology Department, "Victor Babeş" University of Medicine and Pharmacy, Timişoara, Romania.

Background: Ischemic heart disease represents the most important cause of mortality worldwide, and the management of patients with ST-elevation myocardial infarction (STEMI) still remains a great challenge. For a great number of patients who do not have immediate access to primary percutaneous coronary intervention (PCI), facilitated angioplasty may be a reasonable therapeutic option.

Areas Of Uncertainty: The goal of reperfusion therapy is achieving repermeabilization of the infarct-related artery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000914DOI Listing
March 2019
6 Reads
1.127 Impact Factor

Benefits and Risks of Anticoagulation in Acute Coronary Syndrome.

Am J Ther 2019 Mar/Apr;26(2):e198-e207

Departement of Cardiology, Emergency Clinical County Hospital of Baia Mare, Baia Mare, Romania.

Background: Both antiplatelets and anticoagulants are necessary in the management of acute coronary syndrome (ACS), although the exact proportion of antithrombotic effect that each drug and class should ideally provide remains a matter of ongoing study.

Area Of Uncertainty: Defining the best combination between the antiplatelet agents and oral anticoagulants (OACs) can be challenging. The choice is particularly important for special categories of patients with ACS who have an indication of a long-term OAC. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000915DOI Listing
March 2019
1 Read

Anticoagulation in Acute Coronary Syndrome: Review of Major Therapeutic Advances.

Am J Ther 2019 Mar/Apr;26(2):e184-e197

Cardiology Clinic, "St. Spiridon" County Emergency Hospital, University of Medicine and Pharmacy "Grigore T. Popa" Iaşi, Romania.

Background: In patients with acute coronary syndrome (ACS), a persistent hypercoagulable state has been demonstrated and antithrombin therapy in addition to platelet inhibition has been proposed.

Areas Of Uncertainty: Vitamin K antagonists (VKAs) were used as oral anticoagulant (OAC) therapy and produced mixed results whereas trials are still ongoing with non-vitamin K OACs (NOACs).

Data Sources: A literature search regarding benefits and risks of different OAC therapies in ACS was conducted through MEDLINE and EMBASE (last 20 years until September 2018). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000913DOI Listing
March 2019
1.127 Impact Factor

The Need to Improve Acute Cardiac Care.

Authors:
Diana Tint

Am J Ther 2019 Mar/Apr;26(2):e183

Faculty of Medicine, Transilvania University, ICCO Clinics Brasov, Romania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000953DOI Listing

Warfarin-Associated Tracheobronchial Calcification.

Am J Ther 2019 Feb 28. Epub 2019 Feb 28.

Department of Medicine, New York Medical College, Metropolitan Hospital Center, Manhattan, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000961DOI Listing
February 2019

Glycerol Used for Controlling the Increased Intracranial Pressure-Related Charles Bonnet Syndrome.

Am J Ther 2019 Feb 28. Epub 2019 Feb 28.

Department of Psychiatry Tri-Service General Hospital School of Medicine National Defense Medical Center Taipei, Taiwan, Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000954DOI Listing
February 2019

Lurasidone-Induced Delirious Mania.

Am J Ther 2019 Feb 28. Epub 2019 Feb 28.

Department of Psychiatry Tri-Service General Hospital, School of Medicine, National Defense Medical Center Taipei, Taiwan, Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000959DOI Listing
February 2019
1 Read

Immunotherapy in Bladder Cancer.

Am J Ther 2019 Feb 28. Epub 2019 Feb 28.

Division of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY.

Background: Bladder cancer is the fifth most common cancer in the United States. Cisplatin-based chemotherapy is the current standard of care in stage IV bladder cancer. It has increased overall survival but rarely results in complete remission, with an overall survival of 14-15 months. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000934DOI Listing
February 2019
6 Reads

Evaluation of Risk Factors and Empiric Antimicrobial Therapy for Acinetobacter baumannii Bacteremia and Impact on Patient Outcomes.

Am J Ther 2019 Feb 28. Epub 2019 Feb 28.

Department of Clinical Pharmacy Methodist University Hospital, Memphis, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000949DOI Listing
February 2019
6 Reads

Severe Thrombocytopenia Due to Intravenous Tirofiban Therapy.

Am J Ther 2019 Feb 28. Epub 2019 Feb 28.

Department of Internal Medicine, Maimonides Medical Center, Brooklyn, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000756DOI Listing
February 2019

Cumulative Electroconvulsive Therapy-Associated Severe Hyperammonemic Encephalopathy: A Case Report.

Am J Ther 2019 Feb 26. Epub 2019 Feb 26.

Department of Psychiatry, Beitou Branch, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan, Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000960DOI Listing
February 2019

Metabolic Monitoring of Child and Adolescent Patients on Atypical Antipsychotics by Psychiatrists and Primary Care Providers.

Am J Ther 2019 Feb 7. Epub 2019 Feb 7.

Department of Psychiatry, McLeod Medical Center, Florence, SC.

Background: Antipsychotic drug use in children has doubled from 2001 to 2007 with concomitant increase in obesity. Second-generation antipsychotic (SGA) medication use is associated with weight gain, metabolic derangements, and blood sugar and lipid abnormalities in children. The American Psychiatric Association and the American Diabetes Association have recommended metabolic monitoring guidelines for patients using SGA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000853DOI Listing
February 2019
5 Reads

Clozapine Might Relieve Rhinotillexomania and Related Epistaxis in Schizophrenia Patients: A Case Report.

Am J Ther 2019 Jan 30. Epub 2019 Jan 30.

Department of Psychiatry, Beitou Branch, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000943DOI Listing
January 2019
6 Reads

Manganese Toxicity Complicating Parenteral Nutrition.

Authors:

Am J Ther 2019 Jan 30. Epub 2019 Jan 30.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000899DOI Listing
January 2019
9 Reads